Treatments · Entity Annotation Prototype (beta)

3articles mentioning treatments

3treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: Immunomodulators ×

Immunomodulators

This treatment is selected. Its supporting articles are shown below.

Immunomodulators3

Articles mentioning Immunomodulators

3 articles · page 1 of 1

Reduced risk of colorectal cancer with non-sulfasalazine 5-ASAs in ulcerative colitis and Crohn’s disease and anti-TNF therapy in ulcerative colitis: a systematic review and meta-analysis

flgastro · abstract · 2025-12-04 · 1 matching annotations

76.9%

Immunomodulators CRC ulcerative colitis colorectal cancer Crohn’s disease 5-ASAs Non-sulfasalazine 5-ASAs IBD

…associated with a reduced risk of CRC/Dys in patients with IBD. Immunomodulators were not associated with a reduced risk (RR 0.92; 95% CI 0.82 t…

Identification of novel molecular drivers, prognostic and diagnostic biomarkers for Inflammatory Bowel Disease (IBD): protocol for the Nottingham/AstraZeneca prospective IBD observational cohort study

bmjopen · abstract · 2025-11-23 · 1 matching annotations

90.0%

anti-TNFα immunomodulators ulcerative colitis Crohn’s disease NHS trusts West of Scotland Research Ethics Committee UC glucocorticosteroids

…, immunomodulators) and targeted advanced treatments, including anti-TNFα, antibodies to p40 subunit of IL-12/23, antibodies to p19 subun…

Withdrawal of antitumour necrosis factor in patients with inflammatory bowel disease in remission: a randomised placebo-controlled clinical trial of GETECCU

gutjnl · abstract · 2025-09-08 · 1 matching annotations

86.0%

immunomodulators anti-TNF inflammatory bowel disease IBD

…atients with inflammatory bowel disease (IBD), while continuing immunomodulators.1…